Prescription & OTC Drugs – Douglas A. GREENE, Rajiv R. Ratan, Thomas I. Bradshaw, Burke Neurological Institute, Neuronasal Inc

Abstract for “Methods for treating brain disorders”

The present disclosure describes intranasal administration of N-acetylcysteine, (NAC), via nose-to brain administration. An analytical technique such as magnetic resonance spectroscopy can be used to monitor the effect of NAC nose-to brain administration. Intranasal nose to brain NAC may be used in some instances to treat a condition such as a brain injury.

Background for “Methods for treating brain disorders”

“INCORPORATION BY RESEARCH”

“Compounds” of the Disclosure

“Purity Of Compounds of The Disclosure”

“Intranasal Nose-to-Brain Delivery”

“Therapeutic Methods”

“Pharmaceutical Compositions”

“Modes of Administration.”

“Dosing”

“Combination Therapy”

“Therapeutic Effects”

“Subjects”

“Clinical Assessment Tools.”

“EXAMPLES”

“Example 1 – Phase I Study on Brain Bioavailability & Safety of Intranasal NAAC”

“Statistical Methods”

“Example 2 – Investigational Product, Dosage and Mode of Administration”

“Example 3 – Study Evaluations and Measurements

“Example 4 – Single Ascending Dose Stud”

“Example 5 – Administration of Nose to Brain NAC”

“Example 6 – Administration of Nose to Brain GSH”

“Example 7 – Measuring Nose to Brain NAC or GSH Delivery Using Magnetic Resonance Spectroscopy

“Example 8 – Administration of Intranasal Nose to Brain NAC to a Subject With a Military-Related Traumatic Head Injury”

“Embodiments”

Summary for “Methods for treating brain disorders”

“INCORPORATION BY RESEARCH”

“Compounds” of the Disclosure

“Purity Of Compounds of The Disclosure”

“Intranasal Nose-to-Brain Delivery”

“Therapeutic Methods”

“Pharmaceutical Compositions”

“Modes of Administration.”

“Dosing”

“Combination Therapy”

“Therapeutic Effects”

“Subjects”

“Clinical Assessment Tools.”

“EXAMPLES”

“Example 1 – Phase I Study on Brain Bioavailability & Safety of Intranasal NAAC”

“Statistical Methods”

“Example 2 – Investigational Product, Dosage and Mode of Administration”

“Example 3 – Study Evaluations and Measurements

“Example 4 – Single Ascending Dose Stud”

“Example 5 – Administration of Nose to Brain NAC”

“Example 6 – Administration of Nose to Brain GSH”

“Example 7 – Measuring Nose to Brain NAC or GSH Delivery Using Magnetic Resonance Spectroscopy

“Example 8 – Administration of Intranasal Nose to Brain NAC to a Subject With a Military-Related Traumatic Head Injury”

“Embodiments”

Click here to view the patent on Google Patents.